Sino Medical Sciences Technology In (688108) — Capital Reinvestment Ratio
Sino Medical Sciences Technology In (688108) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.52 Million) in capital expenditures (CN¥6.63 Million). Check tangible equity quality of Sino Medical Sciences Technology In to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sino Medical Sciences Technology In Capital Reinvestment Ratio (2016–2025)
This chart tracks Sino Medical Sciences Technology In's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Sino Medical Sciences Technology In generate cash.
Annual Capital Reinvestment Ratio for Sino Medical Sciences Technology In (2016–2025)
Year-by-year Capital Reinvestment Ratio for Sino Medical Sciences Technology In from 2016 to 2025. See Sino Medical Sciences Technology In (688108) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥161.87 Million | CN¥45.80 Million | ▼ -47.0% |
| 2024 | 0.53x | CN¥131.24 Million | CN¥70.02 Million | ▼ -55.2% |
| 2023 | 1.19x | CN¥56.84 Million | CN¥67.67 Million | ▼ -25.6% |
| 2020 | 1.60x | CN¥70.51 Million | CN¥112.78 Million | ▲ +22.2% |
| 2019 | 1.31x | CN¥137.61 Million | CN¥180.04 Million | ▲ +29.1% |
| 2018 | 1.01x | CN¥97.56 Million | CN¥98.87 Million | ▼ -6.5% |
| 2017 | 1.08x | CN¥70.32 Million | CN¥76.25 Million | ▲ +3.3% |
| 2016 | 1.05x | CN¥42.24 Million | CN¥44.32 Million | — |